Target intelligence / Profile preview

Human papillomavirus type 16 L1 protein assembly interface (HPV16 L1 interface)

Target
HPV16 L1 interface
Molecular classification
Viral structural protein, Protein-protein interaction (PPI) site
01

Overview

The Human papillomavirus type 16 (HPV16) L1 pentamer–pentamer interface is a critical structural site responsible for the assembly and stability of the viral capsid. The L1 protein, the major capsid component, organizes into pentameric units called capsomeres, which then interlock via their C-terminal invading arms to form a stable T=7 icosahedral shell (Modis et al., 2002, EMBO J). This interface involves the docking of the h4 helix from one pentamer into a hydrophobic pocket on an adjacent pentamer, a process essential for protecting the viral genome and facilitating host cell entry (Cardone et al., 2014, J. Virol.). As a therapeutic target, this interface is highly attractive for the development of small-molecule antivirals designed to disrupt capsid assembly or promote premature disassembly. Unlike prophylactic vaccines that induce antibodies against the L1 surface, targeting the assembly interface offers a potential therapeutic strategy for treating existing HPV infections by preventing the production of infectious progeny. Research has identified several experimental small molecules and peptides that occupy these hydrophobic pockets, effectively neutralizing the virus by interfering with its structural integrity (Li et al., 2016, Structure).

Other names
HPV16 L1 pentamer-pentamer contact siteHPV16 L1 inter-pentameric interfaceHPV16 L1 capsomere-capsomere interfaceHPV16 L1 C-terminal arm docking site
02

Mechanism of action

Inhibition of viral capsid assembly and stabilization by blocking inter-pentameric protein-protein interactions, leading to the formation of non-infectious or malformed viral particles.

03

Biological functions

Viral capsid assemblyVirion maturationGenome encapsulationHost cell entryStructural stabilization
04

Disease associations

Cervical cancerOropharyngeal cancerAnal cancerVulvar cancerPenile cancerHuman papillomavirus infection
05

Safety considerations

Potential for viral resistance through interface mutationsRequirement for high specificity to avoid interference with host protein-protein interactionsChallenges in drug delivery to basal epithelial cellsPotential for incomplete viral clearance leading to persistent infection
06

Interacting drugs

Experimental small-molecule assembly inhibitors (e.g., thiadiazolobenzimidazole derivatives)

2 more in the full profile.

07

Biomarkers

HPV16 DNAL1 protein expressionHPV16 E6/E7 mRNAViral load

Beyond the preview

Go deeper on Human papillomavirus type 16 L1 protein assembly interface (HPV16 L1 interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 16 L1 protein assembly interface (HPV16 L1 interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call